Differences in healthcare utilisation between users and non-users of homeopathic products in Spain: Results from three waves of the National Health Survey (2011-2017).
Identifieur interne : 000036 ( Main/Exploration ); précédent : 000035; suivant : 000037Differences in healthcare utilisation between users and non-users of homeopathic products in Spain: Results from three waves of the National Health Survey (2011-2017).
Auteurs : Jaime Pinilla [Espagne] ; Alejandro Rodriguez-Caro [Espagne]Source :
- PloS one [ 1932-6203 ] ; 2019.
Descripteurs français
- KwdFr :
- Acceptation des soins par les patients (psychologie), Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Enquêtes de santé (MeSH), Espagne (MeSH), Femelle (MeSH), Homéopathie (effets indésirables), Homéopathie (psychologie), Humains (MeSH), Matière médicale (effets indésirables), Mâle (MeSH), Prestations des soins de santé (tendances).
- MESH :
- effets indésirables : Homéopathie, Matière médicale.
- psychologie : Acceptation des soins par les patients, Homéopathie.
- tendances : Prestations des soins de santé.
- Adolescent, Adulte, Adulte d'âge moyen, Enquêtes de santé, Espagne, Femelle, Humains, Mâle.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Delivery of Health Care (trends), Female (MeSH), Health Surveys (MeSH), Homeopathy (adverse effects), Homeopathy (psychology), Humans (MeSH), Male (MeSH), Materia Medica (adverse effects), Middle Aged (MeSH), Patient Acceptance of Health Care (psychology), Spain (MeSH).
- MESH :
- chemical , adverse effects : Materia Medica.
- geographic : Spain.
- adverse effects : Homeopathy.
- psychology : Homeopathy, Patient Acceptance of Health Care.
- trends : Delivery of Health Care.
- Adolescent, Adult, Female, Health Surveys, Humans, Male, Middle Aged.
Abstract
OBJECTIVE
To compare the differences in the use of healthcare services: visits to the doctor and hospitalisation, performance of routine tests, and preventive influenza vaccination, between users and non-users of homeopathic products.
METHODS
We used the microdata for adults over 15 years old from three waves of the Spanish National Health Survey, corresponding to the years 2011, 2014 and 2017. We proposed a comparative design of a quasi-experimental type, considering as the treatment group the respondents who said that they had used homeopathic products in the past two weeks; and another group, for control, comprising respondents who said that they had not used this type of products, but only conventional medicines, with observable characteristics similar to those of the treatment group. We used a model for rare events logistics regression (relogit) to estimate the probability of using homeopathy. From the propensity score and a vector of control variables, we used techniques of genetic matching to match individuals from the treatment group with similar individuals belonging to the control group.
RESULTS
There are no statistically significant differences between users and non-users of homeopathy in visits to the general practitioner (P>|z| 0.387), to the specialist (P>|z| 0.52), in hospitalisations (P>|z| 0.592) or in the use of emergency services (P>|z| 0.109). Nor were there any statistically significant differences in the performance of routine tests, except for the faecal occult blood test, which is more prevalent in users of homeopathic products. 20.9% of users of homeopathy had done this test compared with 15.3% of non-users (P>|z| 0.022). There are also significant differences in vaccination against influenza with 12.6% of homeopathy users stating that they had been vaccinated in the last influenza campaign, against 21.0% of non-users (P>|z| <0.001). The health conditions which homeopathy users reported were constipation (OR: 1.65 CI: 1.16-2.36), malignant tumour (OR: 1.60 CI: 1.09-2.36) osteoporosis (OR: 1.49 CI: 1.05-2.10), varicose veins (OR: 1.35 CI: 1.05-1.74) and allergy (OR: 1.35 CI: 1.06-1.72).
CONCLUSIONS
Differences in the use of healthcare resources between users and non-users of homeopathic products have not been found to be statistically significant in Spain. It has been shown that most homeopathic products are used as a complement to treatment with conventional medicine. Nevertheless, our results highlight some warning signs which should raise the attention of healthcare authorities. The use of these therapies in patients with malignant tumours and the rejection of vaccines are warning signs of a possible health hazard in the long term.
DOI: 10.1371/journal.pone.0216707
PubMed: 31083699
PubMed Central: PMC6513046
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Differences in healthcare utilisation between users and non-users of homeopathic products in Spain: Results from three waves of the National Health Survey (2011-2017).</title><author><name sortKey="Pinilla, Jaime" sort="Pinilla, Jaime" uniqKey="Pinilla J" first="Jaime" last="Pinilla">Jaime Pinilla</name><affiliation wicri:level="1"><nlm:affiliation>Department of Quantitative Methods, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Quantitative Methods, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria</wicri:regionArea><wicri:noRegion>Las Palmas de Gran Canaria</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Centre for Research in Health and Economics, Universitat Pompeu Fabra, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centre for Research in Health and Economics, Universitat Pompeu Fabra, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName><orgName type="university">Université Pompeu Fabra</orgName></affiliation></author><author><name sortKey="Rodriguez Caro, Alejandro" sort="Rodriguez Caro, Alejandro" uniqKey="Rodriguez Caro A" first="Alejandro" last="Rodriguez-Caro">Alejandro Rodriguez-Caro</name><affiliation wicri:level="1"><nlm:affiliation>Department of Quantitative Methods, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Quantitative Methods, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria</wicri:regionArea><wicri:noRegion>Las Palmas de Gran Canaria</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:31083699</idno><idno type="pmid">31083699</idno><idno type="doi">10.1371/journal.pone.0216707</idno><idno type="pmc">PMC6513046</idno><idno type="wicri:Area/Main/Corpus">00019</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00019</idno><idno type="wicri:Area/Main/Curation">000019</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000019</idno><idno type="wicri:Area/Main/Exploration">000019</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Differences in healthcare utilisation between users and non-users of homeopathic products in Spain: Results from three waves of the National Health Survey (2011-2017).</title><author><name sortKey="Pinilla, Jaime" sort="Pinilla, Jaime" uniqKey="Pinilla J" first="Jaime" last="Pinilla">Jaime Pinilla</name><affiliation wicri:level="1"><nlm:affiliation>Department of Quantitative Methods, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Quantitative Methods, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria</wicri:regionArea><wicri:noRegion>Las Palmas de Gran Canaria</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Centre for Research in Health and Economics, Universitat Pompeu Fabra, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centre for Research in Health and Economics, Universitat Pompeu Fabra, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName><orgName type="university">Université Pompeu Fabra</orgName></affiliation></author><author><name sortKey="Rodriguez Caro, Alejandro" sort="Rodriguez Caro, Alejandro" uniqKey="Rodriguez Caro A" first="Alejandro" last="Rodriguez-Caro">Alejandro Rodriguez-Caro</name><affiliation wicri:level="1"><nlm:affiliation>Department of Quantitative Methods, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Quantitative Methods, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria</wicri:regionArea><wicri:noRegion>Las Palmas de Gran Canaria</wicri:noRegion></affiliation></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Delivery of Health Care (trends)</term><term>Female (MeSH)</term><term>Health Surveys (MeSH)</term><term>Homeopathy (adverse effects)</term><term>Homeopathy (psychology)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Materia Medica (adverse effects)</term><term>Middle Aged (MeSH)</term><term>Patient Acceptance of Health Care (psychology)</term><term>Spain (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acceptation des soins par les patients (psychologie)</term><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Enquêtes de santé (MeSH)</term><term>Espagne (MeSH)</term><term>Femelle (MeSH)</term><term>Homéopathie (effets indésirables)</term><term>Homéopathie (psychologie)</term><term>Humains (MeSH)</term><term>Matière médicale (effets indésirables)</term><term>Mâle (MeSH)</term><term>Prestations des soins de santé (tendances)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Materia Medica</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Homeopathy</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Homéopathie</term><term>Matière médicale</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Acceptation des soins par les patients</term><term>Homéopathie</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Homeopathy</term><term>Patient Acceptance of Health Care</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Prestations des soins de santé</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Delivery of Health Care</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Female</term><term>Health Surveys</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enquêtes de santé</term><term>Espagne</term><term>Femelle</term><term>Humains</term><term>Mâle</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>To compare the differences in the use of healthcare services: visits to the doctor and hospitalisation, performance of routine tests, and preventive influenza vaccination, between users and non-users of homeopathic products.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>We used the microdata for adults over 15 years old from three waves of the Spanish National Health Survey, corresponding to the years 2011, 2014 and 2017. We proposed a comparative design of a quasi-experimental type, considering as the treatment group the respondents who said that they had used homeopathic products in the past two weeks; and another group, for control, comprising respondents who said that they had not used this type of products, but only conventional medicines, with observable characteristics similar to those of the treatment group. We used a model for rare events logistics regression (relogit) to estimate the probability of using homeopathy. From the propensity score and a vector of control variables, we used techniques of genetic matching to match individuals from the treatment group with similar individuals belonging to the control group.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>There are no statistically significant differences between users and non-users of homeopathy in visits to the general practitioner (P>|z| 0.387), to the specialist (P>|z| 0.52), in hospitalisations (P>|z| 0.592) or in the use of emergency services (P>|z| 0.109). Nor were there any statistically significant differences in the performance of routine tests, except for the faecal occult blood test, which is more prevalent in users of homeopathic products. 20.9% of users of homeopathy had done this test compared with 15.3% of non-users (P>|z| 0.022). There are also significant differences in vaccination against influenza with 12.6% of homeopathy users stating that they had been vaccinated in the last influenza campaign, against 21.0% of non-users (P>|z| <0.001). The health conditions which homeopathy users reported were constipation (OR: 1.65 CI: 1.16-2.36), malignant tumour (OR: 1.60 CI: 1.09-2.36) osteoporosis (OR: 1.49 CI: 1.05-2.10), varicose veins (OR: 1.35 CI: 1.05-1.74) and allergy (OR: 1.35 CI: 1.06-1.72).</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Differences in the use of healthcare resources between users and non-users of homeopathic products have not been found to be statistically significant in Spain. It has been shown that most homeopathic products are used as a complement to treatment with conventional medicine. Nevertheless, our results highlight some warning signs which should raise the attention of healthcare authorities. The use of these therapies in patients with malignant tumours and the rejection of vaccines are warning signs of a possible health hazard in the long term.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31083699</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Differences in healthcare utilisation between users and non-users of homeopathic products in Spain: Results from three waves of the National Health Survey (2011-2017).</ArticleTitle><Pagination><MedlinePgn>e0216707</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0216707</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To compare the differences in the use of healthcare services: visits to the doctor and hospitalisation, performance of routine tests, and preventive influenza vaccination, between users and non-users of homeopathic products.</AbstractText><AbstractText Label="METHODS">We used the microdata for adults over 15 years old from three waves of the Spanish National Health Survey, corresponding to the years 2011, 2014 and 2017. We proposed a comparative design of a quasi-experimental type, considering as the treatment group the respondents who said that they had used homeopathic products in the past two weeks; and another group, for control, comprising respondents who said that they had not used this type of products, but only conventional medicines, with observable characteristics similar to those of the treatment group. We used a model for rare events logistics regression (relogit) to estimate the probability of using homeopathy. From the propensity score and a vector of control variables, we used techniques of genetic matching to match individuals from the treatment group with similar individuals belonging to the control group.</AbstractText><AbstractText Label="RESULTS">There are no statistically significant differences between users and non-users of homeopathy in visits to the general practitioner (P>|z| 0.387), to the specialist (P>|z| 0.52), in hospitalisations (P>|z| 0.592) or in the use of emergency services (P>|z| 0.109). Nor were there any statistically significant differences in the performance of routine tests, except for the faecal occult blood test, which is more prevalent in users of homeopathic products. 20.9% of users of homeopathy had done this test compared with 15.3% of non-users (P>|z| 0.022). There are also significant differences in vaccination against influenza with 12.6% of homeopathy users stating that they had been vaccinated in the last influenza campaign, against 21.0% of non-users (P>|z| <0.001). The health conditions which homeopathy users reported were constipation (OR: 1.65 CI: 1.16-2.36), malignant tumour (OR: 1.60 CI: 1.09-2.36) osteoporosis (OR: 1.49 CI: 1.05-2.10), varicose veins (OR: 1.35 CI: 1.05-1.74) and allergy (OR: 1.35 CI: 1.06-1.72).</AbstractText><AbstractText Label="CONCLUSIONS">Differences in the use of healthcare resources between users and non-users of homeopathic products have not been found to be statistically significant in Spain. It has been shown that most homeopathic products are used as a complement to treatment with conventional medicine. Nevertheless, our results highlight some warning signs which should raise the attention of healthcare authorities. The use of these therapies in patients with malignant tumours and the rejection of vaccines are warning signs of a possible health hazard in the long term.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pinilla</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Quantitative Methods, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Research in Health and Economics, Universitat Pompeu Fabra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Caro</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8080-3094</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Methods, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008419">Materia Medica</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006306" MajorTopicYN="N">Health Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006705" MajorTopicYN="N">Homeopathy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008419" MajorTopicYN="N">Materia Medica</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31083699</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0216707</ArticleId><ArticleId IdType="pii">PONE-D-18-31653</ArticleId><ArticleId IdType="pmc">PMC6513046</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JAMA Oncol. 2018 Oct 1;4(10):1375-1381</Citation><ArticleIdList><ArticleId IdType="pubmed">30027204</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Methods Med Res. 2018 Apr;27(4):1240-1257</Citation><ArticleIdList><ArticleId IdType="pubmed">27460539</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2016 Nov;138(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">27940756</ArticleId></ArticleIdList></Reference><Reference><Citation>Complement Ther Med. 2002 Jun;10(2):100-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12481958</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 2016 Apr;106(4):743-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26890179</ArticleId></ArticleIdList></Reference><Reference><Citation>Fam Pract. 2015 Feb;32(1):62-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25381009</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Health Res. 2014 Jan;24(1):114-23</Citation><ArticleIdList><ArticleId IdType="pubmed">24406483</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsch Komplementmed. 2012;19 Suppl 2:18-28</Citation><ArticleIdList><ArticleId IdType="pubmed">23883941</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers. 2007 Dec;75(6):1083-102</Citation><ArticleIdList><ArticleId IdType="pubmed">17995458</ArticleId></ArticleIdList></Reference><Reference><Citation>Fam Pract. 1997 Aug;14(4):302-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9283851</ArticleId></ArticleIdList></Reference><Reference><Citation>Sociol Compass. 2014 Jun;8(6):805-822</Citation><ArticleIdList><ArticleId IdType="pubmed">25177359</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2003 Aug 1;158(3):280-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12882951</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Pharmacol. 2002 Apr;58(1):61-4</Citation><ArticleIdList><ArticleId IdType="pubmed">11956675</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Public Health. 2017 Feb 1;27(suppl_1):55-62</Citation><ArticleIdList><ArticleId IdType="pubmed">28355646</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Public Health. 2018 Jun;46(4):448-455</Citation><ArticleIdList><ArticleId IdType="pubmed">28975853</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsch Komplementmed. 2012;19 Suppl 2:37-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23883943</ArticleId></ArticleIdList></Reference><Reference><Citation>J Causal Inference. 2015 Sep;3(2):237-249</Citation><ArticleIdList><ArticleId IdType="pubmed">29430383</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Catalogne</li></region><settlement><li>Barcelone</li></settlement><orgName><li>Université Pompeu Fabra</li></orgName></list><tree><country name="Espagne"><noRegion><name sortKey="Pinilla, Jaime" sort="Pinilla, Jaime" uniqKey="Pinilla J" first="Jaime" last="Pinilla">Jaime Pinilla</name></noRegion><name sortKey="Pinilla, Jaime" sort="Pinilla, Jaime" uniqKey="Pinilla J" first="Jaime" last="Pinilla">Jaime Pinilla</name><name sortKey="Rodriguez Caro, Alejandro" sort="Rodriguez Caro, Alejandro" uniqKey="Rodriguez Caro A" first="Alejandro" last="Rodriguez-Caro">Alejandro Rodriguez-Caro</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000036 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000036 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:31083699
|texte= Differences in healthcare utilisation between users and non-users of homeopathic products in Spain: Results from three waves of the National Health Survey (2011-2017).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:31083699" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |